Biotechnology

SynBioBeta is Connecting the Global Synthetic Biology Industry at their 4th Annual London Conference

Wed, 03/02/2016 - 10:00
On April 6th - 8th, SynBioBeta with support of event host SynbiCITE, will once again bring together the synthetic biology community for the fourth annual SynBioBeta London 2016 Conference at Imperial College London, UK.
A Echalier

University of Leicester scientist wins Domainex’s STAR Award to support her search for a treatment for non-Hodgkin lymphomas

Wed, 03/02/2016 - 09:00
Domainex Ltd is pleased to announce that the recipient of its latest Discovery STAR Award is Dr Aude Echalier, Lecturer in Structural Biology of Cancer Related Targets at the University of Leicester.

New study looks at the impact of Boards on Biotech company performance

Tue, 02/02/2016 - 10:30
UK companies performing less well than those in mainland Europe

Domainex and Cresset Announce Drug Discovery Services Alliance

Mon, 25/01/2016 - 09:00
Domainex Ltd. and Cresset Discovery Services, today announced an alliance to provide their customers with world-class laboratory-based and computational drug discovery services through a seamless combination of their respective capabilities in chemistry and biology.

New Automated SPR Levels the Playing Field in Protein Science

Wed, 20/01/2016 - 16:30
OpenSPR-XT will accelerate discoveries in protein science by offering affordable & fully automated binding kinetics for life sciences researchers from academia to industry.

Leading Healthcare and Life Science Executives Support UK Report Analysing the Realities of Investment in the Sector

Tue, 19/01/2016 - 12:30
With contributions from Rt. Hon. George Freeman MP, Neil Woodford, Imperial Innovations, The London Stock Exchange, BIA and EY, plus case studies on 5 of the UK’s leading success stories, the report illustrates the fundamental truths about investing in the UK.

Synpromics and Cell Therapy Catapult Collaborate to Develop Novel Large Scale Viral Vector Manufacturing Platform Based on Stable Producer Cell Lines

Mon, 11/01/2016 - 12:00
Synpromics Ltd and The Cell Therapy Catapult annouce collaboration to reduce cost and increase scale and efficiency of viral vector manufacturing.

Biotech and Money London Adds Pharma Forum Day to Help UK Life Science Companies Assess Partnership Potential with Big Pharma

Thu, 17/12/2015 - 12:00
London, UK, 17th December 2015 / Sciad Newswire / Biotech and Money London, a C-level executive conference that helps build linkages and business opportunities for UK life science

Synpromics Announces Collaboration with Avalanche Biotechnologies

Thu, 17/12/2015 - 11:00
Synthetic promoters to be developed for gene therapy in eye disease

Controlling the ‘Social Life’ of Proteins Aims to Transform Drug Discovery

Tue, 15/12/2015 - 12:00
A new £3.4 million programme will develop new tools to understand which interactions between proteins in the human body are relevant to disease.

Pages